Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: a UK parallel cohort study using CPRD.
暂无分享,去创建一个
C. Cooper | M. Javaid | D. Prieto-Alhambra | A. Delmestri | N. Shaw | S. Hawley | R. Pinedo-Villanueva
[1] S. Poyrazoglu,et al. Nationwide Turkish Cohort Study of Hypophosphatemic Rickets , 2020, Journal of Clinical Research in Pediatric Endocrinology.
[2] M. Marmot. Social justice, human rights and health equity. , 2020, Journal of public health.
[3] R. Lachmann,et al. Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study , 2020, Quality of Life Research.
[4] M. Marmot,et al. Association between socioeconomic status and the development of mental and physical health conditions in adulthood: a multi-cohort study. , 2020, The Lancet. Public health.
[5] J. Zwerina,et al. Multidisciplinary patient care in X‐linked hypophosphatemic rickets: one challenge, many perspectives , 2020, Wiener Medizinische Wochenschrift.
[6] A. Rothenbuhler,et al. Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH). , 2020, Metabolism: clinical and experimental.
[7] N. Shaw,et al. Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal , 2019, Advances in Therapy.
[8] D. Greco,et al. Reducing socio-economic inequalities in all-cause mortality: a counterfactual mediation approach , 2019, International journal of epidemiology.
[9] C. Cooper,et al. Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis , 2019, The Journal of clinical endocrinology and metabolism.
[10] M. Maghnie,et al. X-linked hypophosphatemic rickets: an Italian experts’ opinion survey , 2019, Italian Journal of Pediatrics.
[11] Spiros C. Denaxas,et al. A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service , 2019, The Lancet. Digital health.
[12] L. Rejnmark,et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia , 2019, Nature Reviews Nephrology.
[13] J. S. San Martin,et al. The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey , 2019, Journal of the Endocrine Society.
[14] Susanne Jung,et al. Oral symptoms and oral health-related quality of life of individuals with x-linked hypophosphatemia , 2019, Head & Face Medicine.
[15] A. Rothenbuhler,et al. X-linked hypophosphatemia: Management and treatment prospects. , 2019, Joint, bone, spine : revue du rhumatisme.
[16] R. Perera,et al. Practice variation in the use of tests in UK primary care: a retrospective analysis of 16 million tests performed over 3.3 million patient years in 2015/16 , 2018, BMC Medicine.
[17] R. Perera,et al. Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests , 2018, British Medical Journal.
[18] Lauren R. Khazem. Physical disability and suicide: recent advancements in understanding and future directions for consideration. , 2018, Current opinion in psychology.
[19] R. Arbuckle,et al. Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC® as Clinical Trial End Points. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[20] M. Marmot,et al. Subjective social status and mortality: the English Longitudinal Study of Ageing , 2018, European Journal of Epidemiology.
[21] M. Oddy,et al. Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations , 2018, Journal of Inherited Metabolic Disease.
[22] L. Smeeth,et al. Identifying social factors amongst older individuals in linked electronic health records: An assessment in a population based study , 2017, PloS one.
[23] R. Nunn. “It’s not all in my head!” - The complex relationship between rare diseases and mental health problems , 2017, Orphanet Journal of Rare Diseases.
[24] Y. Ben-Shlomo,et al. The effect of social deprivation on hip fracture incidence in England has not changed over 14 years: an analysis of the English Hospital Episodes Statistics (2001–2015) , 2017, Osteoporosis International.
[25] C. Cooper,et al. Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia , 2016, Orphanet Journal of Rare Diseases.
[26] K. Bhaskaran,et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD) , 2015, International journal of epidemiology.
[27] D. Brennan,et al. Health-related quality of life and income-related social mobility in young adults , 2014, Health and Quality of Life Outcomes.
[28] K. Bhaskaran,et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases , 2013, Journal of public health.
[29] M. Krzyzanowska,et al. BIOSOCIAL CORRELATES OF INTER-GENERATIONAL SOCIAL MOBILITY IN A BRITISH COHORT , 2013, Journal of Biosocial Science.
[30] Marko Elovainio,et al. American Journal of Epidemiology Original Contribution Socioeconomic Differences in Cardiometabolic Factors: Social Causation or Health-related Selection? Evidence from the Whitehall Ii Cohort Study, 1991–2004 , 2022 .
[31] M. Marmot,et al. Economic difficulties and physical functioning in Finnish and British employees: contribution of social and behavioural factors. , 2011, European journal of public health.
[32] I. Holm,et al. A clinician's guide to X‐linked hypophosphatemia , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] P. Vestergaard,et al. Phenotype Presentation of Hypophosphatemic Rickets in Adults , 2010, Calcified Tissue International.
[34] J. Pettifor. What’s new in hypophosphataemic rickets? , 2008, European Journal of Pediatrics.
[35] Roger Newson,et al. Multiple—test Procedures and Smile Plots , 2003 .
[36] S. Takeda,et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[37] T. Meitinger,et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.
[38] E. Dahl. Social mobility and health: cause or effect? , 1996, BMJ.
[39] A. Poustka,et al. A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets , 1995, Nature Genetics.
[40] P. Kao,et al. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. , 1994, The New England journal of medicine.
[41] B. Morgenstern,et al. HYPOPHOSPHATAEMIC RICKETS: FINAL HEIGHT AND CLINICAL SYMPTOMS IN ADULTS , 1989, The Lancet.
[42] W. Murphy,et al. X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. , 1989, Radiology.